DBV Technologies
Bagneux
About DBV Technologies
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $453.4M
- Funding stage: M&A
- Last round: Post-IPO Secondary (Oct 2025)
- Ticker: epa:DBV
- Website: dbv-technologies.com
- Phone: +33 (0)1 55 42 78 78
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/dbv-technologies-87300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.